Search hospitals > Michigan > Flint
Singh and Arora Hematology Oncology, PC
Claim this profileFlint, Michigan 48532
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Colorectal Cancer
Conducts research for Lung Cancer
57 reported clinical trials
10 medical researchers
Summary
Singh and Arora Hematology Oncology, PC is a medical facility located in Flint, Michigan. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Breast cancer, Colorectal Cancer, Lung Cancer and other specialties. Singh and Arora Hematology Oncology, PC is involved with conducting 57 clinical trials across 111 conditions. There are 10 research doctors associated with this hospital, such as Ammar Sukari, Anthony F. Shields, Anteneh A. Tesfaye, and Elisabeth I Heath, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage III
Stage IV
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Ammar SukariWayne State University/Karmanos Cancer Institute2 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Squamous Cell Carcinoma
29 reported clinical trials
45 drugs studied
Anthony F. ShieldsBarbara Ann Karmanos Cancer Institute5 years of reported clinical research
Studies Cancer
Studies Solid Tumors
22 reported clinical trials
65 drugs studied
Anteneh A. TesfayeWayne State University/Karmanos Cancer Institute5 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
19 reported clinical trials
39 drugs studied
Elisabeth I Heath, MDKarmanos Cancer Institute4 years of reported clinical research
Expert in Prostate Cancer
Studies Prostatic Neoplasm
18 reported clinical trials
40 drugs studied
Clinical Trials running at Singh and Arora Hematology Oncology, PC
Esophageal Adenocarcinoma
Gastric cancer
Prostate Cancer
Esophageal Cancer
Cardiotoxicity
Breast cancer
Multiple Myeloma
Cancer
Breast Cancer
Brain Metastasis
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Singh and Arora Hematology Oncology, PC?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.